Naprosyn Ec (Naproxen)

Naproxen, the active ingredient in Naprosyn Ec, is a nonsteroidal anti-inflammatory drug (NSAID) presented as an enteric‑coated tablet for oral use. It treats mild to moderate pain, inflammatory conditions such as rheumatoid arthritis and osteoarthritis, dysmenorrhea, and gout flares in adults, and is commonly prescribed for short‑term symptom relief.

GNH USA supplies Naprosyn Ec as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Naproxen is an NSAID that reduces inflammation and pain by inhibiting cyclooxygenase enzymes. - Rheumatoid arthritis: reduces joint inflammation and pain, improving mobility. - Osteoarthritis: alleviates chronic joint discomfort and stiffness. - Dysmenorrhea: lessens menstrual cramps and associated pelvic pain. - Gout flares: decreases acute joint inflammation and tenderness. - Mild to moderate pain: provides analgesia for headaches, dental pain, and musculoskeletal aches.

Adverse reactions may occur with naproxen therapy.

Common Side Effects: - Gastrointestinal discomfort or dyspepsia. - Headache. - Dizziness. - Mild skin rash. - Elevated blood pressure. - Nausea.

Serious or Rare Side Effects: - Gastrointestinal ulceration or bleeding. - Cardiovascular events such as myocardial infarction or stroke. - Severe skin reactions (e.g., Stevens‑Johnson syndrome). - Hepatic enzyme elevation or liver injury. - Acute renal impairment or failure. - Anaphylaxis or severe hypersensitivity reactions.

Before initiating naproxen, consider the following safety measures. - Assess gastrointestinal risk: evaluate history of ulcers or bleeding. - Monitor renal function: check creatinine in patients with kidney disease. - Avoid use in late pregnancy: NSAIDs are contraindicated in the third trimester. - Use the lowest effective dose: limit duration to reduce adverse events. - Avoid concomitant anticoagulants: increased risk of bleeding. - Store at ambient temperature: keep in the original pack, protect from moisture.

Naproxen can interact with several medicines; awareness helps prevent complications.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): heightened bleeding risk. - Other NSAIDs or aspirin: additive gastrointestinal toxicity. - Selective serotonin reuptake inhibitors (SSRIs): increased hemorrhage potential. - Lithium: naproxen may raise lithium concentrations. - Methotrexate: reduced clearance leading to toxicity.

Moderate Interactions (Monitor Closely):\n- ACE inhibitors or ARBs: possible reduction in renal function. - Diuretics: may enhance renal adverse effects. - Beta‑blockers: potential attenuation of antihypertensive effect. - Corticosteroids: synergistic risk of gastrointestinal ulceration. - Antihypertensive agents: monitor blood pressure control.